Ramanan Laxminarayan | Academic Influence

Ramanan Laxminarayan's AcademicInfluence.com Rankings

Ramanan Laxminarayan

Medical

#1429

World Rank

#1766

Historical Rank

Epidemiology

#277

World Rank

#294

Historical Rank

medical Degrees

Ramanan Laxminarayan

Economics

#2578

World Rank

#2936

Historical Rank

economics Degrees

Download Badge

Medical
Economics

Ramanan Laxminarayan's Degrees

PhD Economics Princeton University
Masters Economics Delhi School of Economics

Similar Degrees You Can Earn

Best Online Master's in Economics

Why Is Ramanan Laxminarayan Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ramanan Laxminarayan Ph.D., M.P.H., FIDSA is an economist and an epidemiologist. He is founder and director of the One Health Trust – formerly known as the Center for Disease Dynamics, Economics & Policy – in Washington, D.C., and director of the World Health Organization Collaborating Center for Antimicrobial Resistance. Laxminarayan is a senior research scholar at Princeton University, an affiliate professor at the University of Washington, a senior associate at the Johns Hopkins Bloomberg School of Public Health, and a visiting professor at the University of Strathclyde. In 2023, he was appointed an honorary visiting professor at the National University of Singapore Saw Swee Hock School of Public Health. His research on epidemiological models of infectious diseases and economic analysis of drug resistance, and research on public health gets attention from leaders and policymakers worldwide. He served on the President Obama's Council of Advisors on Science and Technology’s antimicrobial resistance working group. He served as a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance from 2015 to 2023. He has served as chairperson of the Global Antibiotic Research and Development Partnership , a not-for-profit organization dedicated to developing new antimicrobials, since its founding. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases Initiative .

(See a Problem?)

Ramanan Laxminarayan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antibiotic resistance—the need for global solutions (2013) (3086)
Global trends in antimicrobial use in food animals (2015) (2225)
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. (2014) (1671)
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 (2018) (1551)
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 (2007) (962)
Antimicrobial resistance in developing countries. Part I: recent trends and current status. (2005) (842)
The global threat of antimicrobial resistance: science for intervention (2015) (834)
Access to effective antimicrobials: a worldwide challenge (2016) (800)
Non-prescription antimicrobial use worldwide: a systematic review. (2011) (707)
Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition (2016) (517)
Vital Signs: Carbapenem-Resistant Enterobacteriaceae (2013) (472)
Global trends in antimicrobial resistance in animals in low- and middle-income countries (2019) (462)
Antibiotic resistance is the quintessential One Health issue (2016) (436)
Epidemiology and transmission dynamics of COVID-19 in two Indian states (2020) (395)
Helminth Infections: Soil-transmitted Helminth Infections and Schistosomiasis (2006) (385)
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. (2002) (374)
Antibiotic Resistance in India: Drivers and Opportunities for Action (2016) (372)
Reducing antimicrobial use in food animals (2017) (358)
Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. (2018) (338)
Rationalizing antibiotic use to limit antibiotic resistance in India+ (2011) (308)
Antimicrobial resistance in developing countries. Part II: strategies for containment. (2005) (306)
Advancement of global health: key messages from the Disease Control Priorities Project (2006) (304)
A Research Agenda for Malaria Eradication: Drugs (2011) (287)
Adult and child malaria mortality in India: a nationally representative mortality survey (2010) (275)
Reproductive, maternal, newborn, and child health (2016) (259)
Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. (2015) (237)
Critical knowledge gaps and research needs related to the environmental dimensions of antibiotic resistance. (2018) (228)
The State of the World's Antibiotics 2015 (2015) (205)
Achieving global targets for antimicrobial resistance (2016) (199)
Seasonality and temporal correlation between community antibiotic use and resistance in the United States. (2012) (196)
Economic burden of antibiotic resistance: how much do we really know? (2014) (195)
Intervention Cost-Effectiveness: Overview of Main Messages (2006) (190)
Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. (2010) (183)
Challenges of drug resistance in the developing world (2012) (172)
Economics of Antibiotic Resistance: A Theory of Optimal Use (2001) (166)
Antimicrobial resistance: one world, one fight! (2015) (161)
The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. (2013) (156)
Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel. (2019) (156)
Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. (2015) (154)
Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam (2013) (151)
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. (2020) (148)
Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model (2016) (146)
Antibiotic development — economic, regulatory and societal challenges (2019) (144)
Antibiotic effectiveness: Balancing conservation against innovation (2014) (142)
Optimal control of epidemics in metapopulations (2009) (138)
Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition (2017) (133)
Benefits of using multiple first-line therapies against malaria (2008) (132)
Improving Antimicrobial Stewardship The Evolution of Programmatic Strategies and Barriers (2011) (131)
Seasonal and Temperature-Associated Increases in Gram-Negative Bacterial Bloodstream Infections among Hospitalized Patients (2011) (129)
International cooperation to improve access to and sustain effectiveness of antimicrobials (2016) (128)
A framework for global surveillance of antibiotic resistance. (2011) (127)
Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance (2007) (122)
Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. (2019) (120)
Global trends in antimicrobial use in aquaculture (2020) (119)
Strategic interactions in multi-institutional epidemics of antibiotic resistance. (2005) (119)
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition (2017) (118)
Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006 (2009) (117)
How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? (2017) (113)
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later. (2020) (110)
Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008–2014☆ (2016) (106)
A sticky situation: the unexpected stability of malaria elimination (2013) (101)
The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study (2018) (99)
Extended-Spectrum β-Lactamase-Producing and Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Children: Trends in the United States, 1999-2011. (2014) (99)
Act now or later? Economics of malaria resistance. (2004) (96)
Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. (2014) (93)
Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty (2017) (91)
The Economic Costs of Withdrawing Antimicrobial Growth Promoters from the Livestock Sector (2015) (91)
Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010 (2013) (87)
Economic incentives and mathematical models of disease (2007) (86)
Unit Cost of Medical Services at Different Hospitals in India (2013) (85)
The Prevalence of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant Escherichia Coli in Poultry Chickens and Variation According to Farming Practices in Punjab, India (2017) (85)
Mental, neurological, and substance use disorders (2016) (84)
Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014 (2017) (83)
Estimated Under-Five Deaths Associated with Poor-Quality Antimalarials in Sub-Saharan Africa (2015) (82)
Trends in Antibiotic Resistance in Coagulase-Negative Staphylococci in the United States, 1999 to 2012 (2013) (79)
Quality of Care -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (78)
Human resources estimates and funding for antibiotic stewardship teams are urgently needed. (2017) (78)
Surveillance of antimicrobial consumption in animal production sectors of low- and middle-income countries: Optimizing use and addressing antimicrobial resistance (2018) (77)
Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index (2019) (77)
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999–2012 (2015) (75)
Clinically immune hosts as a refuge for drug-sensitive malaria parasites (2008) (75)
Antibiotic resistance: mitigation opportunities in livestock sector development. (2017) (71)
“One-Size-Fits-All”? Optimizing Treatment Duration for Bacterial Infections (2012) (69)
Covid-19 risks and response in South Asia (2020) (69)
Antimicrobial resistance: The complex challenge of measurement to inform policy and the public (2017) (66)
Synthesizing epidemiological and economic optima for control of immunizing infections (2011) (66)
Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure (2018) (66)
India's vaccine deficit: why more than half of Indian children are not fully immunized, and what can--and should--be done. (2011) (65)
UN High-Level Meeting on antimicrobials—what do we need? (2016) (65)
Poverty and prevalence of antimicrobial resistance in invasive isolates. (2016) (63)
Communicating trends in resistance using a drug resistance index (2011) (62)
Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? (2006) (61)
The Socioeconomic and Institutional Determinants of Participation in India’s Health Insurance Scheme for the Poor (2013) (60)
Childhood vaccines and antibiotic use in low- and middle-income countries (2020) (59)
Corrigendum to “The global threat of antimicrobial resistance: science for intervention” [New Microbes New Infect 6 (2015): 22–29] (2015) (58)
Cost‐effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India (2009) (57)
Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999–2012 (2016) (57)
Economic Benefit of Tuberculosis Control (2007) (56)
Validity of ICD-9-CM Coding for Identifying Incident Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: Is MRSA Infection Coded as a Chronic Disease? (2011) (55)
Disease Control Priorities in Developing Countries (2013) (55)
Tobacco initiation, cessation, and change: evidence from Vietnam. (2004) (55)
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty (2010) (55)
A global subsidy: key to affordable drugs for malaria? (2009) (53)
Global and Regional Causes of Death: Patterns and Trends, 2000–15 -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (53)
Reduced burden of childhood diarrheal diseases through increased access to water and sanitation in India: A modeling analysis. (2017) (52)
Global Priorities for Addressing the Burden of Mental, Neurological, and Substance Use Disorders -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (52)
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance (2021) (51)
Controlling Avian Influenza in Chickens (2007) (51)
Pandemics: Risks, Impacts, and Mitigation -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (51)
Refuge Strategies for Managing Pest Resistance in Transgenic Agriculture (2002) (50)
The Stability of Malaria Elimination (2013) (50)
Reassessing the value of vaccines. (2014) (50)
Global survey of polymyxin use: A call for international guidelines☆ (2013) (49)
Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access (2018) (49)
Tackling antimicrobial resistance at global and local scales. (2015) (48)
Use antimicrobials wisely (2016) (47)
Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae (2018) (46)
Costs of surgical procedures in Indian hospitals (2013) (46)
Reproductive, Maternal, Newborn, and Child Health: Key Messages of This Volume -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (44)
On the implications of endogenous resistance to medications. (2002) (44)
Complementary and Alternative Medicine (2006) (44)
Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016 (2017) (42)
Global Burden of Mental, Neurological, and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010 -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (42)
Battling resistance to antibiotics and pesticides: an economic approach. (2003) (40)
Africa Centres for Disease Control and Prevention’s framework for antimicrobial resistance control in Africa (2018) (40)
Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim. (2014) (40)
The overlooked pandemic of antimicrobial resistance (2022) (39)
Superinfection and the evolution of resistance to antimalarial drugs (2012) (39)
Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure (2018) (38)
Costs, Effectiveness, and Cost-Effectiveness of Selected Surgical Procedures and Platforms (2015) (37)
Antimicrobial resistance-a threat to neonate survival. (2016) (37)
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework (2021) (37)
Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases (2017) (36)
The Human Capital and Productivity Benefits of Early Childhood Nutritional Interventions (2017) (36)
Sequential development and exploitation of an exhaustible resource: do monopoly rights promote conservation? (2005) (36)
Cost-Effectiveness of “Golden Mustard” for Treating Vitamin A Deficiency in India (2010) (36)
State-wise estimates of current hospital beds, intensive care unit (ICU) beds and ventilators in India: Are we prepared for a surge in COVID-19 hospitalizations? (2020) (36)
Does reducing malaria improve household living standards? (2004) (36)
Demand- and supply-side determinants of diphtheria-pertussis-tetanus nonvaccination and dropout in rural India (2017) (35)
Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006 (2010) (35)
Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009–2010: A Pragmatic Retrospective Observational Study (2015) (35)
Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA. (2015) (35)
Drug-Resistant Infections (2017) (35)
Economics of Antibiotic Growth Promoters in Livestock (2015) (34)
Excessive use of medically important antimicrobials in food animals in Pakistan: a five-year surveillance survey (2019) (33)
Economic Issues and Antibiotic Resistance in the Community (2002) (33)
Economics of Antibiotic Use in U.S. Swine and Poultry Production (2015) (33)
Global investments in TB control: economic benefits. (2009) (32)
‘Antibiotic footprint’ as a communication tool to aid reduction of antibiotic consumption (2019) (32)
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway. (2017) (32)
Respiratory Fluoroquinolone Use and Influenza (2011) (31)
Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Infections in Children: A Two-Center Case-Case-Control Study of Risk Factors and Outcomes in Chicago, Illinois. (2014) (31)
The unintended effects of cash transfers on fertility: evidence from the Safe Motherhood Scheme in India (2016) (31)
Incentives for Surveillance of Infectious Disease Outbreaks (2009) (31)
The unsurprising story of MDR-TB resistance in India. (2012) (31)
Early Childhood Nutrition Is Positively Associated with Adolescent Educational Outcomes: Evidence from the Andhra Pradesh Child and Parents Study (APCAPS). (2015) (30)
Economics of Infectious Diseases (2011) (30)
Counting the lives saved by DOTS in India: a model-based approach (2017) (29)
Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis (2010) (29)
Introduction and geographic availability of new antibiotics approved between 1999 and 2014 (2018) (28)
Economic and Behavioral Influencers of Vaccination and Antimicrobial Use (2020) (27)
Financing health improvements in India. (2008) (27)
SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study (2021) (26)
Valuing vaccines using value of statistical life measures. (2014) (26)
Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach (2017) (25)
Pooling RT-PCR or NGS samples has the potential to cost-effectively generate estimates of COVID-19 prevalence in resource limited environments (2020) (25)
Antibiotic Effectiveness: New Challenges in Natural Resource Management (2010) (25)
Should New Antimalarial Drugs Be Subsidized? (2006) (25)
How Broad Should the Scope of Antibiotics Patents Be (2002) (25)
Clinical outcome of dual colistin‐ and carbapenem‐resistant Klebsiella pneumoniae bloodstream infections: A single‐center retrospective study of 75 cases in India (2017) (24)
Anthropometric, cognitive, and schooling benefits of measles vaccination: Longitudinal cohort analysis in Ethiopia, India, and Vietnam (2019) (24)
The value of information : methodological frontiers and new applications in environment and health (2012) (24)
A Global Antimicrobial Conservation Fund for Low- and Middle-Income Countries. (2016) (23)
Disease Control Priorities, Third Edition (2017) (23)
Returns on Investment in the Continuum of Care for Reproductive, Maternal, Newborn, and Child Health -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (23)
Antibacterial R&D incentives (2011) (22)
Re-Imagining School Feeding : A High-Return Investment in Human Capital and Local Economies (2018) (22)
Faropenem Consumption is Increasing in India. (2016) (22)
Current costs & projected financial needs of India's Universal Immunization Programme (2016) (21)
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic (2021) (21)
Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis (2021) (21)
Interventions to Reduce Maternal and Newborn Morbidity and Mortality -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (21)
Emerging and re-emerging infectious disease threats in South Asia: status, vulnerability, preparedness, and outlook (2017) (21)
Simulating the impact of excise taxation for disease prevention in low-income and middle-income countries: an application to South Africa (2018) (20)
Fiscal and Externality Rationales for Alcohol Policies (2009) (20)
The potential global gains in health and revenue from increased taxation of tobacco, alcohol and sugar-sweetened beverages: a modelling analysis (2020) (20)
Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study. (2014) (20)
Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012. (2019) (19)
Incentives for Reporting Infectious Disease Outbreaks (2011) (19)
Vaccination coverage in India: a small area estimation approach. (2015) (18)
Cost-effectiveness of Disease Interventions in India (2007) (18)
Bacterial Resistance and the Optimal Use of Antibiotics (2001) (17)
Fiscal and Externality Rationales for Alcohol Taxes (2006) (17)
India health report: nutrition 2015 (2015) (17)
All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study (2021) (17)
Early-Life Nutrition Is Associated Positively with Schooling and Labor Market Outcomes and Negatively with Marriage Rates at Age 20-25 Years: Evidence from the Andhra Pradesh Children and Parents Study (APCAPS) in India. (2018) (17)
Haemophilus influenzae type b vaccination and anthropometric, cognitive, and schooling outcomes among Indian children (2019) (17)
Self-enforcing regional vaccination agreements (2016) (16)
Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: Evidence from the Global Enteric Multicenter Study (2020) (16)
The value of information: ‘Methodological Frontiers and New Applications for Realizing Social Benefit’ workshop (2010) (16)
Diversify or Focus? Spending to Combat Infectious Diseases When Budgets are Tight (2010) (16)
The need for better evidence to evaluate the health & economic benefits of India's Rashtriya Swasthya Bima Yojana (2015) (16)
Variation in cost and performance of routine immunisation service delivery in India (2018) (15)
Reducing stunting in India: what investments are needed? (2016) (15)
Twitter to engage, educate, and advocate for global antibiotic stewardship and antimicrobial resistance. (2019) (15)
Incentives for Reporting Disease Outbreaks (2014) (15)
Childhood vaccinations and adult schooling attainment: Long-term evidence from India's Universal Immunization Programme (2020) (15)
Health and economic benefits of scaling up a home-based neonatal care package in rural India: a modelling analysis. (2016) (15)
Biological Limits on Agricultural Intensification: An Example from Resistance Management (2000) (14)
Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine (2021) (14)
Is Antimicrobial Resistance a Bigger Problem in Tertiary Care Hospitals Than in Small Community Hospitals in the United States? (2017) (14)
Are physicians' prescribing decisions sensitive to drug prices? Evidence from a free-antibiotics program. (2015) (14)
Advocacy for Increased International Efforts for Antimicrobial Stewardship Actions in Low-and Middle-Income Countries on Behalf of Alliance for the Prudent Use of Antimicrobials (APUA), Under the Auspices of the International Society of Antimicrobial Chemotherapy (ISAC) (2020) (14)
Levels and Causes of Maternal Mortality and Morbidity -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (13)
The Value of Information (2012) (13)
Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza? (2019) (13)
The Lancet Infectious Diseases Commission Antibiotic resistance—the need for global solutions (2013) (13)
The Affordable Medicines Facility—malaria: killing it slowly (2012) (13)
Fighting Antibiotic Resistance : Can Economic Incentives Play a Role ? (2001) (13)
A one health framework to estimate the cost of antimicrobial resistance (2020) (13)
Incentivizing hospital infection control (2019) (13)
Managing partially protected resources under uncertainty (2010) (12)
Is the efficacy of antibiotic prophylaxis for surgical procedures decreasing? Systematic review and meta-analysis of randomized control trials (2018) (12)
India’s Battle against COVID-19: Progress and Challenges (2020) (12)
Using Oral Vancomycin Prescriptions as a Proxy Measure for Clostridium difficile Infections: A Spatial and Time Series Analysis (2011) (12)
The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017 (2019) (12)
Postgraduate education in nutrition in south Asia: a huge mismatch between investments and needs (2014) (12)
Impact of informational feedback to clinicians on antibiotic-prescribing rates in a tertiary care hospital in Delhi (2015) (11)
Global Problems, Smart Solutions: Infectious Disease, Injury, and Reproductive Health (2012) (11)
How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making? (2019) (11)
A role for private sector laboratories in public health surveillance of antimicrobial resistance. (2016) (11)
Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods (2018) (11)
Management of Severe and Moderate Acute Malnutrition in Children -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (11)
Health Policy Analysis: Applications of Extended Cost-Effectiveness Analysis Methodology in Disease Control Priorities, Third Edition -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (11)
The value of tracking antibiotic consumption. (2014) (11)
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016 (2018) (11)
Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush (2021) (11)
Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India (2018) (11)
Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (11)
Monopoly Extraction of an Exhaustible Resource with Two Markets (2004) (10)
The Impact of a National Early Childhood Development Program on Future Schooling Attainment: Evidence from Integrated Child Development Services in India (2020) (10)
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections (2013) (9)
Childhood Mental and Developmental Disorders -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (9)
From Financing to Fevers: Lessons of an Antimalarial Subsidy Program (2012) (9)
Will a Global Subsidy of Artemisinin-Based Combination Treatment (Act) for Malaria Delay the Emergence of Resistance and Save Lives? (2005) (9)
On Accelerated Testing for COVID-19 Using Group Testing (2020) (9)
India's Health Initiative: Financing Issues and Options (2007) (9)
Antimicrobials: access and sustainable eff ectiveness 1 Access to eff ective antimicrobials: a worldwide challenge (2015) (8)
Economics of Antibiotic Resistance (1998) (8)
Applying a One Health Approach in Global Health and Medicine: Enhancing Involvement of Medical Schools and Global Health Centers (2021) (8)
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study (2022) (8)
Social, cultural and economic aspects of antimicrobial resistance (2020) (8)
Who is at the highest risk from COVID-19 in India? Analysis of health, healthcare access, and socioeconomic indicators at the district level (2020) (8)
The quadruple burden of sepsis (2017) (8)
Universal Health Coverage and Intersectoral Action for Health (2017) (8)
Determinants of cost of routine immunization programme in India (2018) (8)
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (8)
The Impact of a National Early Childhood Development Program on Future Schooling Attainment: Evidence from ICDS in India (2016) (7)
Status, challenges and gaps in antimicrobial resistance surveillance around the world. (2021) (7)
An agent-based simulation modelling approach to extended cost-effectiveness analysis of health interventions (2013) (7)
Disease Control Priorities (2016) (7)
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project (2020) (7)
Public finance of universal routine childhood immunization in India: district-level cost estimates (2021) (7)
Community-Based Care to Improve Maternal, Newborn, and Child Health -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (7)
Relationship between early‐life nutrition and ages at menarche and first pregnancy, and childbirth rates of young adults: Evidence from APCAPS in India (2019) (7)
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem? (2021) (6)
Funders: The missing link in equitable global health research? (2022) (6)
Challenges in Antibiotic R&D Calling for a Global Strategy Considering Both Short- and Long-Term Solutions. (2019) (6)
Socioeconomic Determinants of Disease Transmission in Cambodia (2000) (6)
Intersectoral Policy Priorities for Health -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (6)
Cost Per DALY Averted in a Surgical Unit of a Private Hospital in India (2016) (6)
Reinvesting in health post-2015 (2013) (6)
The effect of the COVID-19 pandemic on routine childhood immunization coverage and timeliness in India: retrospective analysis of the National Family Health Survey of 2019–2021 data (2022) (6)
Breastfeeding Duration and Adolescent Educational Outcomes: Longitudinal Evidence From India (2017) (5)
7 Infectious Disease , Injury , and Reproductive Health (2013) (5)
Antibiotic resistance : the unfolding crisis (2007) (5)
Quantifying uncertainty in intervention effectiveness with structured expert judgement: an application to obstetric fistula (2015) (5)
Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus (2022) (5)
Very Early Childhood Development -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (5)
Is methicillin-susceptible Staphylococcus aureus (MSSA) sequence type 398 confined to Northern Manhattan? Rising prevalence of erythromycin- and clindamycin-resistant MSSA clinical isolates in the United States. (2014) (5)
Levels and Causes of Mortality under Age Five Years -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (5)
The Benefits of a Universal Home-Based Neonatal Care Package in Rural India: An Extended Cost-Effectiveness Analysis -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (5)
Crafting a system-wide response to healthcare-associated infections (2012) (4)
Cost-Effectiveness of Interventions for Reproductive, Maternal, Neonatal, and Child Health -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (4)
Trans-boundary commons in infectious diseases (2016) (4)
Diarrheal Diseases -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (4)
Structured Expert Judgment for Informing the Return on Investment in Surveillance: The Case of Environmental Public Health Tracking (2015) (4)
On the importance of incentives in hospital infection control spending. (2005) (4)
East North Central Region Has the Highest Prevalence of Vancomycin-Resistant Enterococcus faecalis in the United States (2013) (4)
Correction to global antibiotic consumption data. (2017) (4)
Antimicrobials: access and sustainable eff ectiveness 5 International cooperation to improve access to and sustain eff ectiveness of antimicrobials (2016) (4)
Measuring the costs of air pollution and health in China. (2009) (4)
The Unintended Effects of a Cash Incentive for Institutional Childbirth on Demographic Transition: Evidence from the Safe Motherhood Scheme in India (2012) (3)
Measuring Antimicrobial Use Needs Global Harmonization (2021) (3)
‘Antibiotic footprint’ as a communication tool to aid reduction of antibiotic consumption—authors’ response (2019) (3)
Gender gaps in cognitive and noncognitive skills among adolescents in India (2022) (3)
Trends in antibiotic resistance among bacteria isolated from blood cultures using a large private laboratory network data in India: 2008-2014 (2015) (3)
Colistin: From the shadows to a One Health approach for addressing antimicrobial resistance. (2023) (3)
Reply to Charra et al.: Global longitudinal assessment of 2019 changes in defined daily doses (2018) (3)
The effect of generic market entry on antibiotic prescriptions in the United States (2021) (3)
Reply to Abat et al.: Improved policies necessary to ensure an effective future for antibiotics (2018) (3)
Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic? (2020) (3)
Economic Responses to the Problem of Drug Resistance (2002) (3)
Universal Health Coverage and Essential Packages of Care -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (3)
'Antibiotic footprint' as a communication tool to aid reduction of antibiotic consumption-authors' response. (2019) (3)
Tracking trends in antibiotic effectiveness using the Drug Resistance Index (2016) (2)
Impact of Malaria Control on the Demand for ACTs (2008) (2)
The potential impact of age and season on methicillin-resistant Staphylococcus aureus prevalence. (2013) (2)
Incentives for surveillance and reporting of infectious disease outbreaks (2007) (2)
Global Crises, Global Solutions: Disease control (2009) (2)
Birth Weight and Cognitive Development during Childhood: Evidence from India (2017) (2)
Associations between private vaccine and antimicrobial consumption across Indian states, 2009–2017 (2021) (2)
Human resources for health: time to move out of crisis mode (2016) (2)
Health and economic benefits of public financing of epilepsy treatment in India: An agentbased simulation model (2016) (2)
Risks to Children under-five in India from COVID-19 (2020) (2)
AB1094-HPR Development of A Patient Reported Self-Assessment Tool for Rheumatology Patients (2016) (2)
Human Interventions on the Evolution of Host-Bacterium Interactions (2008) (2)
Are Physicians’ Prescribing Decisions Sensitive to Drug Prices? Evidence from a Free-Antibiotics Program (2010) (2)
Keeping One Row Ahead of the Bugs (2004) (2)
Can Early Childhood Nutrition Improve Adult Educational Attainment in India? Evidence from the ICDS Program (2016) (2)
Public health facility quality and child immunization outcomes in rural India: A decomposition analysis (2022) (2)
AB1397 Use of WII fit® in balance training in osteoporosis (2013) (2)
The right combination of carrots and sticks. (2009) (2)
Illicit Drug Dependence -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (2)
Interventions to Improve Reproductive Health -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (2)
Sewage surveillance of antibiotic resistance holds both opportunities and challenges (2022) (2)
Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface. (2023) (1)
Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable Diseases (2020) (1)
Palliative Care and Pain Control -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (1)
Republished: Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition (2016) (1)
Socioeconomic and Institutional Determinants of Healthcare Provider Choice in India (2013) (1)
Dynamics and control of antibiotic resistance in structured metapopulations (2006) (1)
Cost-Effectiveness Analysis in Disease Control Priorities, Third Edition -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (1)
The Impact of Childhood Nutrition on Schooling Attainment of Non-Migrant Adults in India: Evidence from the ICDS Program (2016) (1)
Burden of Reproductive Ill Health -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (1)
Introduction: On the Economics of Resistance (2010) (1)
Figure 1.1, Causes of Maternal and Child Deaths (2016) (1)
COVID-19 and Outpatient Antibiotic Prescriptions in the United States: A County-Level Analysis (2023) (1)
Gender Gaps in Cognitive and Noncognitive Skills: Roles of Ses and Gender Attitudes (2021) (1)
The Loss from Pandemic Influenza Risk -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (1)
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections (2013) (1)
O16.2 Evidence, politics and cultures in policymaking: policy analysis of hpv vaccine introduction in india (2015) (1)
Health Gains and Financial Risk Protection Afforded by Treatment and Prevention of Diarrhea and Pneumonia in Ethiopia: An Extended Cost-Effectiveness Analysis -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (1)
Factors driving antimicrobial resistance in low- and middle-income countries (2014) (1)
Bioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysis (2015) (1)
Preliminary draft , comments welcome Malaria , Adaptation and Crop Choice (2003) (1)
Annual Rates of Decline in Child, Maternal, Tuberculosis, and Noncommunicable Disease Mortality across 109 Low- and Middle-Income Countries from 1990 to 2015 -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (1)
Annex 3 E . Methods for Appraisal of Essential UHC Interventions (2017) (1)
Incentivizing responsible antibiotic use (2018) (1)
Malaria Vaccine Impact on Drug-Susceptible and Resistant Cases and Deaths: A Modeling Study (2022) (1)
Figure 19.3, [Cost-Effectiveness: Intervention at Birth through...]. (2006) (1)
High-Quality Diagnosis: An Essential Pathology Package -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (1)
Tracking Antibiotic Effectiveness Worldwide 1999-2014 Using the Drug Resistance Index (2016) (1)
Adding to the mantra: vaccines prevent illness and death, and preserve existing antibiotics. (2022) (1)
Vaccines for Children in Low- and Middle-Income Countries -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (1)
Saving Diabetic Feet in Africa : Cape Town action declaration 2016 : diabetes (2016) (1)
Reproductive, Maternal, and Child Mortality and Morbidity and the Unmet Need for Family Planning (2016) (1)
Impact of malaria control on the demand for artemisinin-based combinations (ACTs) (2008) (0)
AB1288-HPR BURTON PATIENT REPORTED OUTCOME MEASURES (B-PROM): STEPS TOWARDS VALIDATION (2020) (0)
DISEASE CONTROL PRIORITIES • THIRD EDITION Series Editors (2016) (0)
Estimating the Impact of Vaccination on Antimicrobial-Resistant Typhoid Fever in Gavi-73 Countries (2021) (0)
Volume and Series Editors (2016) (0)
Adult Mental Disorders -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (0)
Malaria among African Children (2006) (0)
Is alcohol consumption undertaxed (2009) (0)
Antibiotic resistance, stewardship, and consumption - Authors' reply. (2019) (0)
Transitioning Immunization Into the Health Care System: Strengthening Routine Immunization in India (2016) (0)
Series and Volume Editors (2016) (0)
Correction: The Socioeconomic and Institutional Determinants of Participation in India’s Health Insurance Scheme for the Poor (2014) (0)
2020: The year of the microbe (2020) (0)
Universal Health Coverage for Mental, Neurological, and Substance Use Disorders: An Extended Cost-Effectiveness Analysis -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (0)
Incentives for Surveillance of Infections Disease Outbreaks (2018) (0)
Childhood vaccines and antibiotic use in low- and middle-income countries (2020) (0)
Advisory Committee to the Editors (2016) (0)
Covid-19 and Women's Age at Marriage: New Evidence from India (2022) (0)
Controlling tuberculosis: What is the benefit, at what cost? (2012) (0)
Controlling Avian Influe nza in Chickens (2007) (0)
Resistance movement: Hospital administrators must join the fight against antibiotic overuse. (2012) (0)
Global Antibiotic Use and Resistance (2016) (0)
ECO-AUDIT: Environmental Benefits Statement (2016) (0)
AB1010 Comparing Digital Tomogram and Ultrasound in Established Rheumatoid Arhritis (2014) (0)
EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach (2022) (0)
Fiscal Instruments for Health in India (2017) (0)
Insulin access for Africa : Cape Town declaration of action 2016 : diabetes (2016) (0)
Box 1.1, From the Series Editors of Disease Control Priorities, Third Edition (2016) (0)
Expanding Indian public health insurance above the poverty line (2016) (0)
ANNEX 3 G . The Role of Surveillance in Achieving UHC (2018) (0)
Effect of the COVID-19 Pandemic on Anthropometric Outcomes in Indian Children: Retrospective Analysis of the 2019-2021 National Family Health Survey Data (2023) (0)
Antibiotic development — economic, regulatory and societal challenges (2019) (0)
Figure 18.5, Antibiotic Use in Meat Production in the United States, 2009–14 (2017) (0)
Economics, Prevention, and Financing of Care for Pregnant Women, Mothers, and Children (2016) (0)
Quantifying uncertainty about future antimicrobial resistance (2017) (0)
A global map of antimicrobial resistance in animals raised for food (2019) (0)
Innovations to Expand Access and Improve Quality of Health Services -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (0)
Panel: The nine volumes of Disease Control Priorities, 3rd edition Volume 1: Essential surgery (2015) (0)
Comment on Schubert, Matoušek and Supp: Stability of pathogen-derived Potato virus Y resistance in potato under field conditions and some aspects of their ecological impact (2005) (0)
THU0484 Zoledronic Acid Infusion and Effect on Renal Function and Calcium in Osteoporosis (2016) (0)
Selected highlights from other journals (2015) (0)
Global Goals on Antimicrobial Stewardship: How Much Progress Have We Made? (2018) (0)
1788. COVID-19 and Antibiotic Prescriptions in the United States: A County-level Analysis (2022) (0)
Type: Invited PresentationPanel Discussion (2016) (0)
Managing Pest Resistance: Timing the Initiation of Refuge Areas (2002) (0)
Foreword 1 (2020) (0)
ANNEX 3A. AN ESSENTIAL PACKAGE OF INTERVENTIONS TO ADDRESS CONGENITAL AND GENETIC DISORDERS (2017) (0)
Interventions To Improve Reproductive Health and Reduce Maternal and Childhood Morbidity and Mortality (2016) (0)
ANNEX 3 B . An Essential Package of Interventions to Address Musculoskeletal Disorders (2017) (0)
Trends in antibiotic resistance among bacteria isolated from blood cultures using a large private laboratory network data in India: 2008-2014 (2015) (0)
Map 1.1, Total Fertility, Maternal Mortality Ratios, and Under-Five Mortality Rates by Country, 2015 (2016) (0)
Policies and Platforms (2016) (0)
Benefit-Cost Analysis in Disease Control Priorities, Third Edition -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (0)
856. Impact of Early Discontinuation of Antimicrobial Therapy on Survival in Culture-Negative Clinically Suspected Serious Infection: An Electronic Health Record-Based Analysis From 111 US Hospitals (2018) (0)
Comment on Schubert , Matoušek and Supp : (2004) (0)
Reply to Chopra and Rizvi (2019) (0)
Universal Health Coverage and Intersectoral Action for Health -- Disease Control Priorities: Improving Health and Reducing Poverty (2017) (0)
Table 69.3, Levels of Evidence for the Efficacy of Selected CAM and TM Approaches (2006) (0)
This could be the last time: the bioeconomics of eradicating malaria. (2009) (0)
SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations (2022) (0)
Cost-Effectiveness of Treatment and Secondary Prevention of Acute Myocardial Infarction in India (2014) (0)
AB0853 Denosumab: clinical perspective and drug survival in a seconday care set up in uk (2017) (0)
Postgraduate education in nutrition in south Asia: a huge mismatch between investments and needs (2014) (0)
Infant and Young Child Growth -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (0)
Disease Control Priorities in Developing Countries , 3 rd Edition Working Paper No . 1 Universal Public Finance of Tuberculosis Treatment in India : An Extended Cost-Effectiveness Analysis (2013) (0)
The option value of antibiotics (2017) (0)
Diagnosis and Treatment of the Febrile Child -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (0)
FRI0688 Fast access to assessment support and treatment (FAAST): innovation to improve service (2018) (0)
Platforms for Health Care and Public Health Interventions (2016) (0)
Special Issue: RFF and human health. (2009) (0)
FRI0622-HPR A New Patient Reported Tool in The Assessment of Physiotherapy for Patients with Knee Osteoarthritis (2016) (0)
Alcohol Use and Alcohol Use Disorders -- Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4) (2016) (0)
Levels and Trends in Low Height-for-Age -- Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2) (2016) (0)
Table 1.1, Essential Interventions for Reproductive Health (2016) (0)
1327Factors associated with optimizing empiric antibiotic therapy in six hospitals (2014) (0)
DCP3 Series Acknowledgments (2016) (0)
Poor Quality Antimalarials: Impact on Clinical Outcomes and Resistance (2014) (0)
Issues Related to Development of Indian Photovoltaic Market (1993) (0)
Water, sanitation and hygiene interventions to reduce healthcare-associated infections among mothers and neonates in low- and middle-income countries (2019) (0)
Global patterns and correlates in the emergence of antimicrobial resistance in humans (2022) (0)
A One Health Framework to Estimate Costs of Antimicrobial Resistance (2020) (0)
How to Build Trust in Covid-19 Vaccines (2020) (0)
Antimicrobial resistance: one world, one fight! (2015) (0)
‘Antibiotic footprint’ as a communication tool to aid reduction of antibiotic consumption—authors’ response (2019) (0)
A one health framework to estimate the cost of antimicrobial resistance (2020) (0)
Response (2017) (0)
Science Journals — AAAS (2018) (0)
The unintended effects of cash transfers on fertility: evidence from the Safe Motherhood Scheme in India (2015) (0)
Reply to Arnold and Beavin. (2018) (0)

This paper list is powered by the following services:

Other Resources About Ramanan Laxminarayan

en.wikipedia.org

What Schools Are Affiliated With Ramanan Laxminarayan?

Ramanan Laxminarayan is affiliated with the following schools: